Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects
Xin Gao,1 Xuemei He,1 Hiroyuki Oshima,2 Daisuke Miyatake,2 Yukio Otsuka,2 Kota Kato,3 Chunxiao Cai,4 Tomasz Wojtkowski,5 Nan Song,6 Yuichiro Kaneko,7 Aixin Shi1 1Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Scien...
Saved in:
Main Authors: | Gao X (Author), He X (Author), Oshima H (Author), Miyatake D (Author), Otsuka Y (Author), Kato K (Author), Cai C (Author), Wojtkowski T (Author), Song N (Author), Kaneko Y (Author), Shi A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
by: He X, et al.
Published: (2022) -
Exposure-response modeling of peficitinib efficacy in patients with rheumatoid arthritis
by: Junko Toyoshima, et al.
Published: (2021) -
Acneiform eruption during peficitinib treatment
by: Reiko Hara, et al.
Published: (2022) -
Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects
by: Dong R, et al.
Published: (2024) -
A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects
by: Yao F, et al.
Published: (2024)